NXPZ-2 is an orally active Keap1-Nrf2 protein-protein interaction (PPI) inhibitor with a Ki value of 95 nM, EC50 value of 120 and 170 nM. NXPZ-2 can dose-dependently ameliorate Abeta[1-42]-Induced cognitive dysfunction, improve brain tissue pathological changes in Alzheimers disease (AD) mouse by increasing neuron quantity and function. NXPZ-2 can inhibit oxidative stress by increasing Nrf2 expression levels and promoting its cytoplasm to nuclear translocation, which is helpful for Keap1-Nrf2 PPI inhibitors and AD associated disease research[1].
Molekulargewicht:
597.66
Reinheit:
98.18
CAS Nummer:
[2254492-08-3]
Formel:
C27H27N5O7S2
Target-Kategorie:
Keap1-Nrf2
Anwendungsbeschreibung:
Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten